Pages
-
-
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
-
-
Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes
-
-
Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial
-
-
Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT
-
-
Effect of Gender on Outcomes After Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex A Subgroup Analysis of the EchoCRT Trial
-
-
Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial
-
-
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
-
-
Associations Between Thrombin Generation and the Risk of Cardiovascular Disease in Elderly Patients: Results From the PROSPER Study
-
-
The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial
-
-
ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment
-
-
Delayed and decreased thrombin generation is associated with stroke in the elderly: results from the prosper study associate
-
-
Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly
-
-
KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly
-
-
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
-
-
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
-
-
KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study
-
-
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
-
-
Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly
-
-
Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
-
-
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
-
-
Activation of Hemostasis and Decline in Cognitive Function in Older People
-
-
Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach
-
-
Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach
-
-
Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial
Pages